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Abstract— Classification of cancer patients into treatment 
groups is essential for appropriate diagnosis to increase survival. 
Previously, a series of papers, largely published in the breast 
cancer domain have leveraged Computational Intelligence (CI) 
developments and tools, resulting in ground breaking advances 
such as the classification of cancer into newly identified classes - 
leading to improved treatment options. However, the current 
literature on the use of CI to achieve this is fragmented, making 
further advances challenging. This paper captures developments 
in this area so far, with the goal to establish a clear, step-by-step 
pipeline for cancer subtype identification. Based on establishing 
the pipeline, the paper identifies key potential advances in CI at 
the individual steps, thus establishing a roadmap for future 
research. As such, it is the aim of the paper to engage the CI 
community to address the research challenges and leverage the 
strong potential of CI in this important area. Finally, we present 
a small set of recent findings on the Nottingham Tenovus 
Primary Breast Carcinoma Series enabling the classification of a 
higher number of patients into one of the identified breast cancer 
groups, and introduce Classifusion: a combination of results of 
multiple classifiers. 
Keywords—Breast Cancer; Classification methods; Consensus 
Classification (Classifusion); Consensus Clustering 
I. INTRODUCTION 
Breast Cancer is one of the most common cancer types in 
women [1]-[3]. It creates the particular difficulty of 
determining the suitable treatment option, among a number of 
complex treatment choices. Recent studies [1]-[5] have solved 
this problem by identifying treatment classes using 
Computational Intelligence (CI), and dividing patients among 
them. This development evolved in the past two decades is 
scattered among several works, as detailed below.  
Eisen et al. [6] introduced hierarchical clustering combined 
with the visual study of dendrograms to analyse the relation 
among the gene expression. The work inspired the use of 
clustering techniques in the cancer profile with respect to genes 
data [7]-[9]. Perou et al. [9] used the hierarchical clustering 
algorithm on gene expression data identifying four molecular 
classes: luminal, HER2, basal and normal. A subsequent study 
further subdivided the luminal into three, namely A, B and C 
[10]. Sotiriou et al. [11] carried forward the research 
partitioning the basal group into two, and eliminating the 
normal group, thus obtaining a total of six groups. With 
advancements in technology, an alternative approach 
developed is to use immunocytochemistry on formalin fixed 
paraffin embedded patient tumour sample. Researchers have 
applied multiple protein biomarkers with relevance to breast 
cancer, investigating the clinical importance of breast cancer 
classes [1]-[5],[12],[13]. 
To address the stability issue of the classification from 
clustering techniques, Monti et al. [12] introduced consensus 
clustering, which considers the consensus across multiple 
clustering algorithms. The idea behind consensus clustering is 
to capture the robustness of sampling variability of the clusters 
formed. If this measure increases, the degree of confidence of 
the overall classification structure also increases. Kellam et al. 
[13] refers to consensus clustering as Clusterfusion, which 
takes into account the results of different clustering algorithms 
and creates robust clusters depending on the consensus across 
the results of multiple clustering algorithms. 
Contrasting and combining the results of multiple 
clustering algorithms is significant to test the stability of the 
clusters formed and of the proposed classification. Similarly, to 
test the stability of the classification outcome we introduce 
‘Classifusion’, which takes the results of different classification 
algorithms and generates a set of robust classes based upon the 
consensus of the results of each algorithm. This allows us to 
infer level of confidence in regard to certain samples belonging 
to a particular class. 
The proposed pipeline to analyse the breast cancer patient’s 
data is introduced in this paper and explained in a step-by-step 
manner with reference to prior work, in particular [1]-[5]. 
Analysis of immunohistochemical data and different clustering 
techniques has led to seven clinical groups for breast cancer 
data composed of protein biomarkers which were collected 
using tumour samples [1],[3]. The work was followed by a 
fuzzy rule based classification algorithm (FuzzyQSBA) 
combined with a novel class assignment method [2]. The 
method classified patients in one of the seven classes, but in the 
process few patients remained unclassified. The aim of this 
work is to develop a cancer subtype identification pipeline and 
present the most recent developments i.e. apply classifiers to 
the previously ‘Not Classified’ breast cancer patients to assess 
similarities with the well-defined classes and thus to assign 
these patients to a specific class. As the ground truth data does 
not exist for this type of cancer-based datasets, the resulting 
classification results are validated by employing a series of 
clustering techniques. Two specific datasets are used as part of 
this paper, the first being the original breast cancer dataset [1] 
and the second called ‘fuzzy membership values dataset’ 
produced as a result of the FuzzyQSBA algorithm mentioned 
above [2]. 
The structure of the paper is as follows: Section II presents 
the Pipeline, which contains the step-by-step (pipeline) 
architecture for the cancer subtype identification. Section III 
explains the methodology used. Section IV contains the results 
and the steps of Classifusion. In Section V the discussion of the 
results is presented. Section VI concludes the paper with future 
directions of research. 
II. PIPELINE 
A. Division of patients into core classes 
To assist prognosis in the context of breast cancer 
treatment, Soria et al. 2010 analysed a breast cancer panel 
composed of 25 protein biomarkers, using several clustering 
algorithms and a consensus approach [1]. The work inspected 
five clustering techniques namely Hierarchical, K-means, 
Partitioning around medoids, Adaptive Resonance Theory and 
Fuzzy C-means. The clustering was followed by the 
computation of validity indices to validate the number of 
clusters and to tackle the issue of cluster stability. Consensus 
among the clusters was evaluated through statistical and 
visualisation methods such as Principal Component 
Visualisation and Boxplots, and by two algorithms namely 
Artificial Neural Network and Rule Extraction. By establishing 
the consensus the work identified six novel cancer subtypes, 
and classified the patients among these core classes. The 
process identified prime biological classes: luminal, HER2 and 
basal (luminal and basal containing distinct subclasses), shown 
in the breast cancer classification structure in Fig.1. The 
procedure classified 61.6% of patients into one of the core 
classes while the remaining 38.4% were assigned to a mixed 
class. Further analysis was required to minimise the 
misclassification. 
B. Reduction of the biomarkers to an essential set 
In a subsequent study, Green et al. 2013 [3] studied 
boxplots of the complete dataset and individual classes 
(described in Soria et al. [1]) and reduced the biomarkers on 
which the classes were derived from 25 to 14. The panel was 
reduced by omitting the biomarkers which had identical overall 
distributions across multiple classes. The study focused on the 
reduction of the number of biomarkers which were sufficient to 
obtain good classification. Using a Naive Bayesian supervised 
classification approach as used in Soria et al. [4], the set of 
biomarkers was further reduced to contain the ten ‘most 
important’ ones. The exhaustive search using the naive Bayes 
classification to choose the best combination of ten biomarkers 
out of 14 was done to also reduce the costs of clinical tests. 
The work also studied the class characterisation by 
analysing the immunohistochemical profiles of the patients. 
Class 6 (HER2) showed heterogeneity in the expression of the 
hormone receptor which led to division of HER2 into two 
subclasses HER2+/ER+ and HER2+/ER- shown in Fig. 2. The 
stable clusters validate the core classes (by Soria et al. [1]) and 
forms basis of further study (by Soria et al. [2]). 
 
 
Fig. 1.  Breast Cancer Classification structure by Soria et al.  [1]. 
 
Fig: 2. Subdivision of HER2+ in two subclasses HER2+/ER+ and 
HER2+/ER- based on immunohistochemical profiles by Green et al. [3] 
C. Division of new patients into core classes by learning the 
pattern 
The analysis was further extended in the work by Soria et 
al. [2], which explored the use of fuzzy methodologies to 
generate a rule set which can classify a large number of 
patients into one of the identified classes. The work makes use 
of a data-driven fuzzy rule based system (FuzzyQSBA) for 
classifying the breast cancer patients. The FuzzyQSBA [2] 
itself is similar to the algorithm developed in Rasmani et al. 
2009 [5]. This latter study makes use of 663 classified patients 
reported in Soria et al. [1]. 
 
Fig: 3. Breast Cancer Classification structure by Soria et al. [2]. 
The algorithm developed in [2] was applied to a well 
characterised dataset of 1,073 breast cancer patients. The 
patients were classified into one of the identified seven classes 
using fuzzy iteration method, similar to the algorithm 
developed in the work Green et al. [3]. The FuzzyQSBA 
algorithm learns the class-labelled breast cancer dataset by 
generating one classification rule per class. The algorithm 
assigns a class membership value to each patient for each of 
the seven classes. A novel class allotment algorithm is 
developed which assigns patients into one of the seven classes. 
In doing so, only 38 out of 1,073 patients were misclassified. 
The class distribution is represented in Fig. 3. The 
classification rules were validated on a new breast cancer 
dataset of 238 patients. Only 12 patients were assigned to ‘Not 
Classified’, giving an excellent classification outcome. The 
complete research pipeline described so far is represented in 
the flowchart diagram reported in Fig. 4. 
 
Fig. 4. Flowchart of the research. 
1) FuzzyQSBA algorithm:  
The FuzzyQSBA algorithm is a fuzzy rule induction 
method based on fuzzy subsethood values i.e. they represent 
the degree to which a fuzzy set is a subset of another fuzzy set. 
The aim of using this technique is to replace crisp weights in 
the Weighted Subsethood-Based Algorithm (WSBA) [2] by 
fuzzy quantifiers. The main difference of Quantifier 
Subsethood-Based Algorithm (QSBA) [2] compared to WSBA 
lies in the interpretation of the inference between 
weights/quantifiers with the linguistic terms. In QSBA both the 
quantifiers and the linguistic terms are fuzzy sets. It offers us 
the flexibility to use t-norm operators to interpret the rule.  
The FuzzyQSBA algorithm consists mainly of these four 
steps: 1) Divide the dataset into subgroups. 2) Calculate fuzzy 
subsethood value. 3) Calculate relative weights. 4) Create 
fuzzy rules. Examples of fuzzy rules are as follows: 
WSBA - “IF A is (A1 OR 0.09A2) AND B is (B2 OR 
0.2B3) AND C is (C1) THEN Output is D". 
FuzzyQSBA - “IF A is ((almost all)A1 OR (a little)A2) and 
B is ((almost all)B2 OR (almost a quarter of)B3) AND C is 
((almost all)C1) THEN Output is D". 
The goal of the above steps was to provide the likelihood of 
membership of each patient in each class. After obtaining these 
values, the class assignment algorithm was applied. For class 
assignment, the two highest membership values were chosen. 
If the difference between the top two values was greater than a 
certain threshold, then the patient was assigned to the class 
with maximum membership. If the difference was below the 
threshold and they both belong to same class family then the 
class with maximum values was chosen. Otherwise the patient 
was not classified. 
D. Classification  
1) Artificial Neural Network (ANN): 
The Artificial Neural Network (ANN) [4],[14],[15] aims to 
classify the data by using the backpropagation learning 
method. The input nodes receive a finite number of inputs from 
the dataset, and pass the data using the synapse to the hidden 
layer. Now using another set of synapse the data is passed to 
the output layer, where a weighted sum is calculated and 
compared with a threshold. The network learns by back 
propagating the error and readjusting the weights. The learning 
process continues until the error reaches the error threshold. 
One of the major reasons behind ANN performing the tasks 
effectively is the nature of network, which enables multiple 
neurons collaterally in the direction of solving the problem. 
2) Nearest Neighbour: 
The Nearest Neighbour algorithm [16] begins by 
considering that data are clustered in their respective class. It 
follows a greedy approach by calculating the distance of the 
test data with each classified data. It then assigns to the class to 
the test data on the basis of minimum distance i.e. the test data 
is assigned to the class with the shortest distance. The 
algorithm is represented in Fig. 5 where xj is one of the ‘Not 
Classified’ breast cancer patients. ω1, ω2 and ω3 represent the 
identified classes in which the patient is intended to be 
classified. 
 
Fig. 5. Nearest Neighbour representation [20]. 
3) Classifusion: 
We introduce a new approach termed as ‘Classifusion’ i.e. 
a consensus across all the classifiers. This is done to provide 
robustness to the result. An object is assigned to a class when it 
is classified in the same class by all the classification 
algorithms. In this work the two classifiers classify the patients 
into one of the identified seven classes.     
E. Clustering 
1) Hierarchical clustering: 
Hierarchical clustering [1],[4],[6],[9] is a technique used 
for cluster analysis. There are two ways to form clusters, the 
first being agglomerative which follows a bottom up approach; 
and the second being divisive, which follows a top down 
approach. In this work the agglomerative strategy is used to 
form clusters.  
The algorithm’s structure is as follows: 1) Assign each item 
to a cluster, i.e. if there are ‘n’ observations then we have ‘n’ 
clusters. 2) Find the closest cluster pair based on the pre-
specified distance. 3) Merge the two clusters and calculate the 
average of them, which will be the representation of the new 
cluster formed. 4) Compute the distance between the new 
cluster and the old clusters. 5) Repeat the steps 2-4 until all the 
observations come under one single cluster.  
2) K-Means: 
K-means clustering [1],[17] works by splitting ‘n’ 
observations into ‘k’ clusters. The algorithm works by 
grouping the observations with similar properties in one group, 
in such a way that it differs from the clusters having different 
properties. The algorithm’s steps are: 1) Start by choosing ‘k’ 
random cluster centres. 2) Calculate the distance of all the ‘n’ 
observations with each centre. 3) Assign the observations to 
the centre with the minimum distance. 4) Recalculate the 
centres by taking the average of each newly formed cluster. 5) 
Repeat steps 2-4 until no new assignment is made. 
3) K-Medoids: 
K-Medoids clustering, also known as Partitioning Around 
Medoids (PAM) [1],[19] aims to partition ‘n’ observations into 
‘k’ clusters. It is related to both the K-means and the medoid 
shift algorithms, and works by minimising the sum of pairwise 
dissimilarities. The algorithm’s steps are: 1) Randomly select 
‘k’ cluster centres (medoids) among ‘n’ observations. 2) 
Assign each point to the closest medoid. 3) For each medoid 
point ‘m’ and non-medoid point ‘o’, swap ‘m’ and ‘o’ and re-
compute the cost. 4) If the new cost is more than the previous 
cost, undo the swap. 5) Repeat steps 2-4 until all the swaps are 
made. 
F. Datasets: 
In this paper, two specific datasets are considered: 
 
1) Breast Cancer Dataset:  
The Breast Cancer Dataset consists of 1,073 patients from 
the Nottingham Tenovus Primary Breast Carcinoma Series 
with operable stages I, II and III. Immunohistochemical 
reactivity [18] for 25 proteins was determined using tissue 
microarray (tumour samples). Among the available 
information, we consider the same ten important protein 
markers suggested by [3] and run our test on them. The same 
reduced set of ten protein biomarkers has been used in the 
recent study by Soria et al. [2] to classify patients in seven 
clinical classes using a data driven FuzzyQSBA algorithm. 
 
2) Fuzzy membership value dataset: 
Soria et al. [2] used the FuzzyQSBA method together with 
a class assignment algorithm to classify the breast cancer 
patients in one of the seven breast cancer classes. The 
algorithm was run on the reduced set of ten protein biomarkers 
from the breast cancer dataset. The FuzzyQSBA algorithm 
[2],[5] developed uses continuous fuzzy quantifiers to create 
the ruleset, which assigns a class membership value to each 
patient for each of the seven classes. The advantage of using a 
fuzzy rule based model is its ability to represent the 
information in the form of if-then rules. This mechanism of 
representation is human understandable and combines several 
rules to generate global behaviour of the system. 
Fuzzy membership values in Fig. 6 are the membership 
values obtained after implementing FuzzyQSBA on the ten 
protein biomarkers, numbered from 1 to 7, and form what we 
call the ‘fuzzy membership value dataset’. The column Class 
represents one of the seven identified classes in which the 
patient is classified. ER, PgR … MUC1 represents the ten 
protein biomarkers from the Breast Cancer Dataset on which 
the FuzzyQSBA algorithm was applied. 
III. METHODOLOGY 
In this work two algorithms namely: Artificial Neural 
Network (ANN) [4],[14],[15] and Nearest Neighbour [16], 
were used for classification of ‘Not Classified’ patients. The 
underlying strategy is based on the following: 1) to classify 
‘Not Classified’ patients in one of the identified classes, 2) to 
increase accuracy by considering multiple classification 
methodologies. To establish a strong and accurate 
classification the algorithms were run on the breast cancer 
dataset consisting of protein markers and on the fuzzy 
membership values of each patient for the seven classes. The 
classification results were validated by applying three 
clustering techniques namely K-means, Hierarchical Clustering 
and K-Medoids. The major steps followed were:  
1) First the ANN classification algorithm was run on the 
1,073-patients breast cancer dataset, where 1,035 were 
classified in one of the seven classes. The ten protein 
biomarkers data of 1,035 patients were used to train the 3-layer 
neural network. The network was tested with multiple numbers 
of hidden nodes, optimal number being 20. After the network 
was trained by updating its weight, the updated network was 
tested on the 38 ‘Not Classified’ patients. Similar steps were 
adopted with the Fuzzy membership value dataset. The labelled 
data of seven class membership values for the 1,035 patients 
was used to train the neural network. After the network learned 
and updated its weight the updated network was tested on the 
38 ‘Not Classified’ patients. The classification outcomes of 
both the datasets are explained in the ‘Results after 
Classification’ segment of the Results section. 
 
        Fig. 6. Tuples of data set produced after applying the FuzzyQSBA algorithm. 
TABLE I.  RESULTS AFTER CLASSIFICATION 
Patient No. Ann original (1) Ann mem (2) Nearest neigh original (3) Nearest neigh mem (4) 1 & 3 2 & 4 Among all 4 
2 1 1 1 1 1 1 1 
3 4 4 4 4 4 4 4 
7 5 5 5 5 5 5 5 
10 5 5 5 5 5 5 5 
14 4 3 4 4 4 0 0 
24 5 5 5 5 5 5 5 
25 4 4 4 4 4 4 4 
32 5 5 5 5 5 5 5 
35 4 4 4 4 4 4 4 
38 4 4 4 4 4 4 4 
 
2) The Nearest Neighbour algorithm calculates the distance 
of 38 ‘Not Classified’ with all the labelled 1,035 patients. It 
assigns the class to 38 patients based on minimum distance. 
The same strategy was used in both the breast cancer dataset 
and the fuzzy membership values dataset. In the breast cancer 
dataset the distance was calculated among ten protein 
biomarkers, and in the fuzzy membership values dataset the 
distance was calculated among the membership values. The 
classification outcome for both the datasets is explained in the 
‘Results after Classification’ segment of the Results section. 
3) The classification results were verified by changing the 
parameters of the classifiers, followed by the consensus 
between the classification algorithms (Classifusion).  
4) K-means [1],[17] was run on both the breast cancer 
dataset and the Fuzzy Membership value dataset. Results of the 
K-Means clustering on the Fuzzy membership value dataset are 
explained in the ‘Results after Clustering’ segment of the 
Results section but the results of the K-means applied to the ten 
protein biomarkers of the breast cancer dataset are not reported 
as they were not informative and therefore dropped from 
further analysis.  
5) Hierarchical [1],[4],[6],[9] and K-medoids [1] clustering 
algorithms were run on both the breast cancer dataset and the 
Fuzzy Membership value dataset. Outcome of both the 
algorithms on both the datasets are explained in the ‘Results 
after Clustering’ segment of the Results section.  
6) Consensus between the results of the different clustering 
algorithms was studied, and compared with the classification 
outcomes. 
IV. RESULTS 
A. Result after Classification: 
Classifusion works by generating a list which checks the 
output class of an instance for each algorithm. If the class is the 
same throughout, then the instance is assigned to the consensus 
class, otherwise the instance is considered to be misclassified. 
The classifusion results are shown in the columns ‘1 & 3’, ‘2 & 
4’ and ‘Among all 4’ of Table I. Abbreviations of the table 
headers are as follows: 
‘Ann original’: ANN algorithm applied to the 10 protein 
biomarkers data with 20 hidden layer nodes and 20,000 
iterations of weight updating. ‘Ann mem’: ANN algorithm 
applied on the fuzzy membership values dataset. ‘Nearest 
neigh original’: nearest neighbour algorithm applied to the 10 
protein biomarkers data. ‘Nearest neigh mem’: nearest 
neighbour algorithm applied on the fuzzy membership values 
dataset. ‘1 & 3’: consensus among the ANN and nearest 
neighbour algorithm applied to the 10 protein biomarkers 
values (classifusion). ‘2 & 4’: consensus (classifusion) among 
the ANN and nearest neighbour algorithm applied to the fuzzy 
membership values. ‘Among all 4’: consensus (classifusion) 
among the ANN and nearest neighbour algorithm for both 
fuzzy membership values and 10 protein biomarkers values 
data sets. 
Table I shows the classification results for ten randomly 
selected patients out of 38. Out of 38 patients, 31 had 
consensus results in case of ‘2 & 4’ i.e. by combining the 
classification results classification of Fuzzy membership values 
dataset. In case of consensus of classification of breast cancer 
dataset, i.e. ‘1 & 3’, the number reduced to 24. The consensus 
of classification for both the datasets (‘Among all 4’) further 
reduced down to 18 out of 38. It can be noted that the fuzzy 
membership values dataset generated better results. One 
TABLE II.  RESULTS AFTER CLUSTERING 
Patient No. K-medoids orig 
(1) 
K-medoids mem 
(2) 
Hierarchical clustering 
orig (3) 
Hierarchical clustering 
mem (4) 
K-means mem 
(5) 
Among all 5 
(1&2&3& 4&5) 
2 1 1 1 1 1 1 
7 5 5 5 5 5 5 
8 4 4 4 4 4 4 
14 2 4 2 4 4 0 
16 1 1 1 1 1 1 
21 4 5 4 5 5 0 
22 3 3 3 3 3 3 
26 4 5 4 4 5 0 
35 4 4 4 4 4 4 
38 4 4 4 4 4 4 
 
explanation for the difference in numbers might be that the 
fuzzy membership values dataset is pre-processed, i.e. the 
dataset is the result of FuzzyQSBA algorithm. 
 A number of observations can be drawn after the 
classification process: firstly, when the algorithms were run on 
the membership values dataset patients were either classified 
into classes corresponding to the highest membership value or 
to the second highest membership value, but no patient was 
classified to class 6 or class 7. The membership values for class 
6 and class 7 were a constant value for all the 38 patients. In 
addition, when the algorithms were run on the ten protein 
biomarkers similar results to those of the membership values 
were obtained, i.e. no patient was classified to class 6 or class 
7. The reason for this was that the values of HER2 in the 
original 1,073 data were either 0 or 300. If the HER2 values 
were 300 then the patient belonged to either class 6 or class 7. 
If the value was 0 then the patient belonged to one of the 
remaining five classes or was misclassified. For all the 38 
patients under investigation in this work, the values of HER2 
were 0. So the patient would never belong to class 6 or class 7. 
We decided to omit class 6 and class 7 in further clustering 
analyses of ‘Not Classified’ breast cancer patients for the 
reasons explained above. 
B. Result after Clustering: 
Individual results (for ten randomly selected patients) after 
each clustering algorithm along with consensus across all the 
methods are reported in Table II. Abbreviation of the table 
headers are as follows: 
‘K-medoids orig’: K-Medoids clustering algorithm applied on 
the ten original protein biomarkers. ‘K-medoids mem’: K-
Medoids clustering algorithm applied on the fuzzy membership 
values. ‘Hierarchical clustering orig’: Hierarchical clustering 
algorithm applied on the ten protein biomarkers. ‘Hierarchical 
clustering mem’: Hierarchical clustering algorithm applied on 
the fuzzy membership values. ‘K-means mem’: K-Means 
clustering algorithm applied on the fuzzy membership values. 
As reported in the classification discussion above we 
eliminated the possibility of cluster 6 and cluster 7, and 
reduced the number of clusters in which the patients could be 
grouped to five. Columns (1) to (5) of Table II represent the 
outcome of K-medoids, Hierarchical clustering and K-means 
clustering applied on the breast cancer dataset and on the fuzzy 
membership value datasets. Out of 38 patients, 20 had 
consensus results across all the five methods. The classification 
result classified 18 out of 38 patients in one of the seven 
classes. Out of 20 patients from clustering, 18 patients are 
exactly the same as those from the classification results. The 
consensus of clustering and classification results therefore 
classifies 18 patients into one of the identified classes. 
K-medoids and Hierarchical clustering produced the same 
results with respect to each other by generating similar clusters. 
They classified the same 20 patients in one of the identified 
classes for both the datasets, and performed slightly better than 
the classification by assigning more patients into one of the 
classes. The results obtained by applying K-means on the 
breast cancer dataset were not informative and were dropped 
from further investigation. But, the results obtained on the 
fuzzy membership values dataset were similar to those 
produced by K-medoids and Hierarchical clustering i.e. they 
classified the same 20 patients into their respective classes.  
K-means clustering algorithm performed poorly on the 
breast cancer dataset, but it produced good results in case of the 
fuzzy membership values dataset. This difference could be due 
to the fact that the fuzzy membership values are processed 
values and have been obtained after applying FuzzyQSBA on 
original breast cancer dataset. 
V. DISCUSSION 
After applying clustering and classification techniques on 
the 38 ‘Not Classified’ patients from the Nottingham breast 
cancer series [2], 18 of the patients can now be assigned to one 
of the seven classes. These patients show strong affinity with 
the original classes 4 and 5. Among 18 patients, six can be 
classified in class 4, 11 in class 5 and the one remaining in 
class 1. Fig. 7 shows the boxplots of the original 1,073 breast 
cancer patients where the y-axis represents the H-score and the 
x-axis represents the ten protein markers.  
 
Fig. 7. Boxplot of 1073 patients. 
Fig. 8 compares the boxplots of the original classes 4 and 5 
with those from the current work. It can be seen that previous 
and new methodologies generate similar boxplots, validating 
the new results. The ‘MUC1’ biomarker has a different mean 
and a different range of values in the new classes 4 and 5. The 
mean is high in both the new classes. Similar behaviour is 
observed for the protein ‘CK7/8’ i.e. the mean is high and the 
range is different in both the new classes 4 and 5. The 
difference in the values of both the biomarkers could be the 
reason for misclassification of these patients in the original 
work by Soria et al. [2]. The strong affinity for class 4 and 
class 5 is validated by the range and the mean of the remaining 
eight biomarkers. 
VI. CONCLUSION 
In this work we have presented a step-by-step pipeline for 
cancer subtype identification with a case study from the breast 
cancer disease. The pipeline forms the basis for the appropriate 
diagnosis to increase survival of cancer patients. The work 
further improves the classification accuracy of the FuzzyQSBA 
result by classifying 18 more patients into one of the seven 
core breast cancer classes. This paper introduces classifusion 
i.e. a combination of results from multiple classifiers to make 
the classification more robust. 
In the future we plan to present the results to clinical 
experts for their interpretation and we will continue working on 
the development of the pipeline and the ‘Classifusion’ 
approach. 
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 Fig. 8. Boxplots of patients (a) Class4 of original classification (b) Class4 of  new methodology (c) Class5 of original classification (d) Class5 of new methodology 
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